2 votes
Speaking exclusively to CNBC-TV18, Bino Pathiparampil, vice president of IIFL Capital says that the market should not needlessly get excited about pharma companies that are bogged down by USFDA issues.
Speaking exclusively to CNBC-TV18, Bino Pathiparampil, vice president of IIFL Capital says that the market should not needlessly get excited about pharma companies that are bogged down by USFDA issues.